ZhuZhou QianJin Pharmaceutical Co Ltd

SHG:600479 China Drug Manufacturers - Specialty & Generic
Market Cap
$735.24 Million
CN¥5.39 Billion CNY
Market Cap Rank
#9830 Global
#2098 in China
Share Price
CN¥10.96
Change (1 day)
-0.90%
52-Week Range
CN¥9.57 - CN¥11.43
All Time High
CN¥14.19
Categories
Companies in China Drug Manufacturers - Specialty & Generic
About

ZhuZhou QianJin Pharmaceutical Co.,Ltd researches, develops, produces, and sells traditional Chinese medicines, chemicals and API, and TCM derivatives in China. The company offers TCM products, chemical medicine, derivative products, and hygienic products, including gynaecological and baby nursing, and maternity pad/ maternity package. ZhuZhou QianJin Pharmaceutical Co.,Ltd was founded in 1966 an… Read more

ZhuZhou QianJin Pharmaceutical Co Ltd (600479) - Net Assets

Latest net assets as of September 2025: CN¥3.24 Billion CNY

Based on the latest financial reports, ZhuZhou QianJin Pharmaceutical Co Ltd (600479) has net assets worth CN¥3.24 Billion CNY as of September 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥4.90 Billion) and total liabilities (CN¥1.66 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets CN¥3.24 Billion
% of Total Assets 66.2%
Annual Growth Rate 14.14%
5-Year Change 13.66%
10-Year Change 59.83%
Growth Volatility 35.78

ZhuZhou QianJin Pharmaceutical Co Ltd - Net Assets Trend (2001–2024)

This chart illustrates how ZhuZhou QianJin Pharmaceutical Co Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for ZhuZhou QianJin Pharmaceutical Co Ltd (2001–2024)

The table below shows the annual net assets of ZhuZhou QianJin Pharmaceutical Co Ltd from 2001 to 2024.

Year Net Assets Change
2024-12-31 CN¥3.14 Billion +3.71%
2023-12-31 CN¥3.03 Billion +7.47%
2022-12-31 CN¥2.82 Billion +4.31%
2021-12-31 CN¥2.70 Billion -2.25%
2020-12-31 CN¥2.76 Billion +5.04%
2019-12-31 CN¥2.63 Billion +8.21%
2018-12-31 CN¥2.43 Billion +8.42%
2017-12-31 CN¥2.24 Billion +7.55%
2016-12-31 CN¥2.08 Billion +6.10%
2015-12-31 CN¥1.96 Billion +41.73%
2014-12-31 CN¥1.39 Billion +15.06%
2013-12-31 CN¥1.20 Billion +13.19%
2012-12-31 CN¥1.06 Billion +7.09%
2011-12-31 CN¥993.56 Million +5.72%
2010-12-31 CN¥939.81 Million -1.21%
2009-12-31 CN¥951.29 Million +8.63%
2008-12-31 CN¥875.75 Million -2.26%
2007-12-31 CN¥895.95 Million +35.83%
2006-12-31 CN¥659.60 Million +10.89%
2005-12-31 CN¥594.85 Million -7.65%
2004-12-31 CN¥644.15 Million +176.38%
2003-12-31 CN¥233.07 Million +25.60%
2002-12-31 CN¥185.56 Million +23.76%
2001-12-31 CN¥149.94 Million --

Equity Component Analysis

This analysis shows how different components contribute to ZhuZhou QianJin Pharmaceutical Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 2045.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Retained Earnings CN¥1.23 Billion 49.93%
Common Stock CN¥424.00 Million 17.22%
Other Comprehensive Income CN¥1.58 Million 0.06%
Other Components CN¥807.24 Million 32.78%
Total Equity CN¥2.46 Billion 100.00%

ZhuZhou QianJin Pharmaceutical Co Ltd Competitors by Market Cap

The table below lists competitors of ZhuZhou QianJin Pharmaceutical Co Ltd ranked by their market capitalization.

Company Market Cap
Draper Esprit plc
PINK:GRWXF
 		$545.34 Million
San Bian Science & Technology Co Ltd
SHE:002112
 		$545.59 Million
Dogan Sirketler Grubu Holding AS
IS:DOHOL
 		$545.61 Million
Jiuzhitang Co Ltd
SHE:000989
 		$545.65 Million
5R02
F:5R02
 		$545.09 Million
Sun TV Network Limited
NSE:SUNTV
 		$545.02 Million
Lander Sports Development Co Ltd
SHE:000558
 		$544.98 Million
Xiamen Jihong Package Technology Ltd
SHE:002803
 		$544.86 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in ZhuZhou QianJin Pharmaceutical Co Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 2,389,672,141 to 2,462,279,280, a change of 72,607,139 (3.0%).
  • Net income of 230,756,619 contributed positively to equity growth.
  • Dividend payments of 152,815,207 reduced retained earnings.
  • Share repurchases of 16,539,280 reduced equity.
  • Other comprehensive income decreased equity by 13,946.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income CN¥230.76 Million +9.37%
Dividends Paid CN¥152.82 Million -6.21%
Share Repurchases CN¥16.54 Million -0.67%
Other Comprehensive Income CN¥-13.95K -0.0%
Other Changes CN¥11.22 Million +0.46%
Total Change CN¥- 3.04%

Book Value vs Market Value Analysis

This analysis compares ZhuZhou QianJin Pharmaceutical Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 1.84x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
  • The price-to-book ratio has decreased from 24.68x to 1.84x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2001-12-31 CN¥0.44 CN¥10.96 x
2002-12-31 CN¥0.54 CN¥10.96 x
2003-12-31 CN¥0.71 CN¥10.96 x
2004-12-31 CN¥2.07 CN¥10.96 x
2005-12-31 CN¥1.90 CN¥10.96 x
2006-12-31 CN¥2.10 CN¥10.96 x
2007-12-31 CN¥2.39 CN¥10.96 x
2008-12-31 CN¥2.33 CN¥10.96 x
2009-12-31 CN¥2.53 CN¥10.96 x
2010-12-31 CN¥2.46 CN¥10.96 x
2011-12-31 CN¥2.48 CN¥10.96 x
2012-12-31 CN¥2.64 CN¥10.96 x
2013-12-31 CN¥2.76 CN¥10.96 x
2014-12-31 CN¥3.07 CN¥10.96 x
2015-12-31 CN¥4.30 CN¥10.96 x
2016-12-31 CN¥4.17 CN¥10.96 x
2017-12-31 CN¥4.49 CN¥10.96 x
2018-12-31 CN¥4.85 CN¥10.96 x
2019-12-31 CN¥5.20 CN¥10.96 x
2020-12-31 CN¥5.42 CN¥10.96 x
2021-12-31 CN¥5.14 CN¥10.96 x
2022-12-31 CN¥5.30 CN¥10.96 x
2023-12-31 CN¥5.66 CN¥10.96 x
2024-12-31 CN¥5.95 CN¥10.96 x

Capital Efficiency Dashboard

This dashboard shows how efficiently ZhuZhou QianJin Pharmaceutical Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 9.37%
  • The company has moderate efficiency in generating returns from equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 6.36%
  • • Asset Turnover: 0.80x
  • • Equity Multiplier: 1.85x
  • Recent ROE (9.37%) is below the historical average (13.26%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2001 25.47% 6.16% 1.68x 2.46x CN¥20.95 Million
2002 23.97% 6.83% 1.62x 2.17x CN¥23.17 Million
2003 23.08% 7.29% 1.63x 1.94x CN¥28.38 Million
2004 7.20% 7.50% 0.76x 1.26x CN¥-17.67 Million
2005 10.35% 8.99% 0.83x 1.38x CN¥2.02 Million
2006 11.21% 11.91% 0.73x 1.29x CN¥7.72 Million
2007 19.85% 25.54% 0.63x 1.24x CN¥86.16 Million
2008 15.26% 16.21% 0.76x 1.24x CN¥44.75 Million
2009 14.17% 14.48% 0.71x 1.37x CN¥38.51 Million
2010 9.58% 8.82% 0.87x 1.25x CN¥-3.77 Million
2011 9.12% 6.59% 0.98x 1.41x CN¥-8.01 Million
2012 12.44% 7.59% 0.96x 1.70x CN¥23.56 Million
2013 12.28% 6.27% 1.04x 1.87x CN¥22.95 Million
2014 9.37% 4.79% 0.98x 1.99x CN¥-7.05 Million
2015 5.64% 3.80% 0.89x 1.67x CN¥-71.72 Million
2016 8.56% 5.22% 0.94x 1.74x CN¥-25.14 Million
2017 11.07% 6.53% 0.97x 1.75x CN¥20.02 Million
2018 12.59% 7.67% 0.96x 1.71x CN¥52.47 Million
2019 13.51% 8.35% 0.92x 1.75x CN¥76.51 Million
2020 13.11% 8.19% 0.86x 1.87x CN¥70.39 Million
2021 14.05% 8.24% 0.90x 1.89x CN¥87.02 Million
2022 13.65% 7.51% 0.87x 2.09x CN¥80.89 Million
2023 13.41% 8.44% 0.81x 1.96x CN¥81.44 Million
2024 9.37% 6.36% 0.80x 1.85x CN¥-15.47 Million

Industry Comparison

This section compares ZhuZhou QianJin Pharmaceutical Co Ltd's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

  • Industry: Drug Manufacturers - Specialty & Generic
  • Average net assets among peers: $4,523,155,599
  • Average return on equity (ROE) among peers: -21.03%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
ZhuZhou QianJin Pharmaceutical Co Ltd (600479) CN¥3.24 Billion 25.47% 0.51x $545.18 Million
Shenzhen Neptunus Bioengineering Co Ltd (000078) $52.15 Million 21.80% 0.58x $623.66 Million
Anhui Fengyuan Pharmaceutical Co Ltd (000153) $765.24 Million 1.30% 0.72x $325.92 Million
Shan Dong Dong-E E-Jiao Co Ltd (000423) $78.32 Million 0.00% 1.98x $3.03 Billion
Wedge Industrial Co Ltd (000534) $1.24 Billion 8.20% 0.96x $1.75 Billion
Yunnan Baiyao Group Co Ltd (000538) $38.34 Billion 14.39% 0.44x $5.59 Billion
Hainan Haiyao Co Ltd (000566) $590.38 Million -258.34% 9.36x $713.60 Million
Tus Pharmaceutical Group Co Ltd (000590) $184.11 Million -46.59% 2.19x $317.60 Million
Northeast Pharmaceutical Group Co Ltd (000597) $1.57 Billion 22.73% 1.61x $426.40 Million
Jilin Aodong Pharmaceutical Group Co Ltd (000623) $2.06 Billion 23.61% 0.46x $2.04 Billion
Renhe Pharmacy Co Ltd (000650) $338.74 Million 2.59% 1.24x $777.45 Million